🔥🐔 BizChicken 🐔🔥
Companies Similar to Yield10 Bioscience, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Green Plains Inc.
Ethanol and Sustainable High-Value Ingredients
Green Plains Inc. produces, markets, and distributes ethanol and sustainable high-value ingredients through its Ethanol Production, Agribusiness and Energy Services, and Partnership segments, focusing on renewable and sustainable solutions for the feed, fuel, and bioproduct needs of a changing world.
Contact | Contact | About | Sustainability | Careers | Careers | Careers | Jobs | Jobs | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | ESG | Jobs | Jobs | Jobs | Careers | Benefits | Culture | Locations | Careers | Careers | Events | Careers | Careers | Careers | Careers | About | About | About
Symbol: GPRE
Recent Price: $8.91
Industry: Chemicals - Specialty
CEO: Mr. Todd A. Becker
Sector: Basic Materials
Employees: 921
Address: 1811 Aksarben Drive, Omaha, NE 68106
Phone: 402 884 8700
Leadership
- Todd Becker, President, Chief Executive Officer and Director
- Phil Boggs, Chief Financial Officer
- Jamie Herbert, Chief Human Resources Officer
- Michelle Mapes, Chief Legal and Administration Officer
- Patrich Simpkins, Chief Transformation Officer
- Grant Kadavy, Executive Vice President, Commercial Operations
- Chris Osowski, Executive Vice President, Operations & Technology
- Leslie van der Meulen, Executive Vice President, Product Marketing & Innovation
Last updated: 2024-12-31
Corteva, Inc.
Seed and Crop Protection
Corteva, Inc. operates in the agriculture business, specializing in seed and crop protection through advanced germplasm, traits, and crop health products. The company provides digital solutions for optimizing yield and offers a wide range of herbicides, insecticides, and seed-applied technologies globally.
About | Contact | Careers | Careers | Vision/Values | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Safety
Symbol: CTVA
Recent Price: $56.56
Industry: Agricultural Inputs
CEO: Mr. Charles Victor Magro B.Sc. (Chem), MBA
Sector: Basic Materials
Employees: 22500
Address: 9330 Zionsville Road, Indianapolis, IN 46268-0735
Phone: 833 267 8382
Leadership
- Chuck Magro, Chief Executive Officer
- Dave Anderson, Special Advisor to the Chief Executive Officer
- Sam Eathington, Executive Vice President, Chief Technology and Digital Officer
- Tim Glenn, Executive Vice President, Seed Business Unit
- David Johnson, Executive Vice President, Chief Financial Officer
- Robert King, Executive Vice President, Crop Protection Business Unit
- Brook Cunningham, Senior Vice President, Chief Strategy Officer
- Cornel B. Fuerer, Senior Vice President, General Counsel
- Audrey Grimm, Senior Vice President, Chief HR & Diversity Officer
- Gregory R. Page, Retired Chairman and Chief Executive Officer, Cargill, Incorporated. Non-Executive Chair of the Board
- Lamberto Andreotti, Retired Chairman and Chief Executive Officer, Bristol-Myers Squibb Company
- Klaus A. Engel, Ph.D., Retired Chief Executive Officer, Evonik Industries AG
- David C. Everitt, Retired President, Agricultural and Turf Division of Deere & Co.
- Janet P. Giesselman, Retired President & General Manager, Dow Oil & Gas
- Karen H. Grimes, Retired Partner, Senior Managing Director & Equity Portfolio Manager, Wellington Management Company
- Michael O. Johanns, Retired United States Senator, Nebraska and former U.S. Secretary of Agriculture
- Rebecca B. Liebert, Ph.D., President and Chief Executive Officer, Lubrizol Corporation
- Marcos M. Lutz, Chief Executive Officer, Ultrapar Participacões S.A.
- Charles V. Magro, Chief Executive Officer, Corteva, Inc.
- Nayaki R. Nayyar, Chief Executive Officer, Securonix, Inc.
- Kerry J. Preete, Retired Executive Vice President and Chief Strategy Officer, Monsanto Company
- Patrick J. Ward, Retired Chief Financial Officer, Cummins Inc.
Last updated: 2024-12-31
CASI Pharmaceuticals, Inc.
EVOMELA
CASI Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes therapeutics and pharmaceutical products focusing on markets in China, the United States, and internationally. Major products include EVOMELA and a pipeline with several investigational products targeting various cancers.
About | About | Contact | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About
Symbol: CASI
Recent Price: $2.93
Industry: Biotechnology
CEO: Dr. Wei-Wu He Ph.D.
Sector: Healthcare
Employees: 176
Address: 9620 Medical Center Drive, Rockville, MD 20850
Phone: 240 864 2600
Last updated: 2024-12-31
Cibus, Inc.
Productivity Traits and Sustainable Ingredients
Cibus, Inc., based in San Diego, California, develops and licenses plant traits to seed companies, focusing on productivity traits for higher agricultural yields and sustainable ingredients to replace fossil fuel-based components.
Symbol: CBUS
Recent Price: $2.58
Industry: Biotechnology
CEO: Mr. Rory Balfour Riggs M.B.A.
Sector: Healthcare
Employees: 183
Address: 6455 Nancy Ridge Drive, San Diego, CA 92121
Phone: 858 450 0008
Last updated: 2024-12-31
Evelo Biosciences, Inc.
EDP1815
Evelo Biosciences, Inc. discovers and develops oral biologics for inflammatory diseases and cancer, with key products like EDP1815 in clinical trials.
Symbol: EVLO
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 66
Address: 620 Memorial Drive, Cambridge, MA 02139
Phone: 617 577 0300
Last updated: 2024-12-31
Akoya Biosciences, Inc.
Pheno Cycler, Pheno Imager, Proxima, in Form Tissue, Phenoptr
Akoya Biosciences, Inc. is a life sciences technology company that provides spatial biology solutions aimed at transforming discovery and clinical research worldwide through products like Pheno Cycler and Pheno Imager.
Symbol: AKYA
Recent Price: $2.38
Industry: Medical - Instruments & Supplies
CEO: Mr. Brian McKelligon
Sector: Healthcare
Employees: 330
Address: 100 Campus Drive, Marlborough, MA 01752
Phone: 855 896 8401
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
Caribou Biosciences, Inc.
CB-010, CB-011, CB-012, CB-020
Caribou Biosciences is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for treating hematologic malignancies and solid tumors, with several product candidates in clinical trials.
About | About | Contact | Contact | Careers | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | About | About | Vision/Values | DEI | Benefits
Symbol: CRBU
Recent Price: $1.61
Industry: Biotechnology
CEO: Dr. Rachel E. Haurwitz Ph.D.
Sector: Healthcare
Employees: 158
Address: 2929 7th Street, Berkeley, CA 94710
Phone: 510 982 6030
Last updated: 2024-12-31
Harvard Bioscience, Inc.
cellular and molecular technology instruments
Harvard Bioscience, Inc. develops, manufactures, and sells technologies and services that support research, discovery, and pre-clinical testing for drug development globally, offering a wide range of instruments for tissue and organ-based lab research.
About | Vision/Values | Leadership | Contact | About | Contact | Contact | Careers | About | About | About | About | About | About | About | About | About | About | About | Careers | About | About
Symbol: HBIO
Recent Price: $2.02
Industry: Medical - Instruments & Supplies
CEO: Mr. James W. Green
Sector: Healthcare
Employees: 391
Address: 84 October Hill Road, Holliston, MA 01746
Phone: 508 893 8999
Leadership
- James Green, Chairman, President & Chief Executive Officer
- Jennifer Cote, Chief Financial Officer and Treasurer
- John Fry, Chief Legal Counsel and Corporation Secretary
- Diane Houston, Vice President, Global IT
- Lori Packer, Vice President, Global People Operations
- Nitya Shetty, Vice President, Global Research and Development
- Ryan Wallace, Senior Vice President, Global Sales
Last updated: 2024-12-31
PDS Biotechnology Corporation
PDS0101
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing multifunctional cancer immunotherapies. Its lead product candidate, PDS0101, is in Phase II clinical trial for treating various human papillomavirus-associated malignancies.
Symbol: PDSB
Recent Price: $1.69
Industry: Biotechnology
CEO: Dr. Frank K. Bedu-Addo Ph.D.
Sector: Healthcare
Employees: 25
Address: 25B Vreeland Road, Florham Park, NJ 07932
Phone: 800 208 3343
Leadership
- Frank Bedu-Addo, Ph.D., Chief Executive Officer, Director
- Stephan Toutain, Chief Operating Officer
- Lars Boesgaard, Chief Financial Officer
- Gregory Conn, Ph.D., Chief Scientific Officer
- Kirk Shepard, M.D., Chief Medical Officer
- Spencer Brown, Senior Vice-President, General Counsel, Corporate Secretary and Compliance Officer
- Rory Cullinane, Vice President of Quality
- Joe Dervan, Ph.D., Vice President of Research and Development
- David Schaaf, M.D., Vice President of Medical Affairs
- Sir Richard Sykes, Director
- Ilian Iliev, Ph.D., Director
- Gregory Freitag, J.D., CPA, Director
- Otis W. Brawley, M.D., Director
- Kamil Ali-Jackson, J.D., Director
- Stephen Glover, Chairman
Last updated: 2024-12-31
Sana Biotechnology, Inc.
N/A
Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.
Symbol: SANA
Recent Price: $1.61
Industry: Biotechnology
CEO: Dr. Steven D. Harr M.D.
Sector: Healthcare
Employees: 328
Address: 188 East Blaine Street, Seattle, WA 98102
Phone: 206 701 7914
Last updated: 2024-12-31
Cassava Sciences, Inc.
simufilam
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead product candidate, simufilam, is a small molecule drug, recently completed Phase 2b clinical trial. The company also develops Sava Dx, a diagnostic to detect Alzheimer's disease.
Symbol: SAVA
Recent Price: $2.40
Industry: Biotechnology
CEO: Mr. Richard Jon Barry
Sector: Healthcare
Employees: 29
Address: 7801 North Capital of Texas Highway, Austin, TX 78731
Phone: 512 501 2444
Last updated: 2024-12-31
Silo Pharma, Inc.
SPC-15
Silo Pharma Inc. is a developmental stage biopharmaceutical company focusing on treatments for stress-induced psychiatric disorders, chronic pain, and CNS diseases through traditional and psychedelic therapies.
Symbol: SILO
Recent Price: $0.89
Industry: Biotechnology
CEO: Mr. Eric Weisblum
Sector: Healthcare
Employees: 3
Address: 677 N. Washington Boulevard, Sarasota, FL 34236
Phone: 718 400 9031
Last updated: 2024-12-31
Sonnet BioTherapeutics Holdings, Inc.
SON-1010, SON-080
Sonnet Bio Therapeutics Holdings, Inc. is a clinical stage oncology-focused biotechnology company developing biologic medicines using its human albumin binding technology. The company is based in Princeton, New Jersey, and has lead candidates such as SON-1010 for non-small cell lung cancer, and SON-080 for neuropathies.
Symbol: SONN
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Pankaj Mohan Ph.D.
Sector: Healthcare
Employees: 12
Address: 100 Overlook Center, Princeton, NJ 08540
Phone: 609-375-2227
Leadership
- Pankaj Mohan, Ph.D., Founder, CEO & Chairman
- Jay Cross, Chief Financial Officer
- John K. Cini, Ph.D., Chief Scientific Officer & Co-Founder
- Susan Dexter, Chief Technical Officer
- Richard Kenney, M.D., Chief Medical Officer
- Albert Dyrness, Board Member
- Nailesh Bhatt, Chief Executive Officer & Board Member
- Raghu Rao, Board Member
- Donald Griffith, Financial Controller
- Lori McNeill, Board Member
Last updated: 2024-12-31
XOMA Corporation
Pre-commercial therapeutic candidates
XOMA Corporation operates as a biotechnology royalty aggregator focusing on enhancing human health by acquiring potential future economics from pre-commercial therapeutic candidates licensed to pharmaceutical or biotech companies. With a portfolio of approximately 70 assets, it focuses on early to mid-stage clinical assets with commercial sales potential.
Symbol: XOMA
Recent Price: $26.09
Industry: Biotechnology
CEO: Mr. Owen P. Hughes Jr.
Sector: Healthcare
Employees: 13
Address: 2200 Powell Street, EmeryVille, CA 94608
Phone: 510 204 7200
Last updated: 2024-12-31
ZIVO Bioscience, Inc.
natural bioactive ingredients
ZIVO Bioscience, Inc. is a research and development company specializing in licensing and selling natural bioactive ingredients derived from proprietary algae cultures, serving the biotech and agtech sectors with intellectual property in human and animal health applications.
Symbol: ZIVO
Recent Price: $20.89
Industry: Biotechnology
CEO: Mr. John B. Payne
Sector: Healthcare
Employees: 8
Address: 21 East Long Lake Road, Bloomfield Hills, MI 48304
Phone: 248 452 9866
Leadership
- John B. Payne, President / Chief Executive Officer / Chairman of the Board
- Keith Marchiando, Chief Financial Officer
- William P. Pfund, Vice-President, Research & Development
- Dr. Amy Steffek, Director, Research & Development
- Dr. Harlan L. Miller III, Vice-President of Technology and Global Supply
- Dr. Laura Belicka, Senior Scientist
- Amy Elizabeth Steffek, Director of Research & Development
- Alison A. Cornell, Executive Vice President & Chief Financial Officer
- Christopher Maggiore, Director
- Nola E. Masterson, Director
- Laith Yaldoo, Director
Last updated: 2024-12-31
Ginkgo Bioworks Holdings, Inc.
platform for cell programming
Ginkgo Bioworks Holdings, Inc. develops a platform used to program cells for biological production of products such as therapeutics, food ingredients, and chemicals. It serves markets in specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
About | About | Contact | Contact | About | About | About | About | Vision/Values | About | About | About | Culture | About | Careers | About | About | About
Symbol: DNA
Recent Price: $9.44
Industry: Biotechnology
CEO: Dr. Jason Kelly
Sector: Healthcare
Employees: 1218
Address: 27 Drydock Avenue, Boston, MA 02210
Phone: 877 422 5362
Last updated: 2024-12-31
Benson Hill, Inc.
Crop OS
Benson Hill operates as a food technology company unlocking natural genetic diversity in plants, focusing on soybeans and yellow peas to enhance food, ingredient, and feed products. It employs advanced AI-driven plant sciences to revolutionize crop development and address nutritional, sustainable, and energy demands.
About | Our Story | About | About | News | Careers | About | Contact | Contact | Contact | Contact
Symbol: BHIL
Recent Price: $2.02
Industry: Agricultural Inputs
CEO: Ms. Adrienne D. Elsner
Sector: Basic Materials
Employees: 270
Address: 1001 North Warson Road, Saint Louis, MO 63132
Phone: 314 222 8218
Last updated: 2024-12-31
BridgeBio Pharma, Inc.
AG10, BBP-265, BBP-831, BBP-631, Encaleret
Bridge Bio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases, with a pipeline of 30 programs including candidates like AG10, BBP-265, and others in various stages of clinical trials.
About | About | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: BBIO
Recent Price: $27.32
Industry: Biotechnology
CEO: Dr. Neil Kumar Ph.D.
Sector: Healthcare
Employees: 550
Address: 421 Kipling Street, Palo Alto, CA 94301
Phone: 650 391 9740
Last updated: 2024-12-31
Yield10 Bioscience, Inc.
Enhanced Oilseed Camelina Sativa
Yield10 Bioscience, Inc. is an agricultural bioscience company that develops technologies to increase crop yields, focusing on the enhanced oilseed Camelina sativa for sustainable biofuels, animal feed, and bioplastic materials.
Symbol: YTEN
Recent Price: $0.34
Industry: Agricultural Inputs
CEO: Dr. Oliver P. Peoples Ph.D.
Sector: Basic Materials
Employees: 29
Address: 19 Presidential Way, Woburn, MA 01801
Phone: 617 583 1700
Leadership
- Dr. Oliver P. Peoples, Ph.D., President, Director, and Chief Executive Officer
- Robert L. Van Nostrand, Director
- Sherri M. Brown, Ph.D., Director
- Richard W. Hamilton, Ph.D., Director
- Willie Loh, Ph.D., Director
- Professor Anthony J. Sinskey, Sc.D., Director
- Kristi Snell Ph.D., Chief Science Officer and Vice President of Research
- Charles B. Haaser, Chief Accounting Officer
- Lynne H. Brum, Vice President, Planning and Corporate Communications
Last updated: 2024-12-31